Literature DB >> 7713314

Diabetes mellitus carrying a mutation in the mitochondrial tRNA(Leu(UUR)) gene.

M Kishimoto1, M Hashiramoto, S Araki, Y Ishida, T Kazumi, E Kanda, M Kasuga.   

Abstract

We screened 214 Japanese NIDDM (non-insulin-dependent) diabetic patients with a family history of diabetes for mutations in the mitochondrial tRNA(Leu(UUR)) gene using polymerase chain reaction-restriction fragment length polymorphism and direct sequencing. Six patients were identified as having an A to G transition at position 3243 (3243 mutation), but no patients were detected with a T to C transition at position 3271, in the mitochondrial tRNA(Leu(UUR)) gene. These two mutations were not present in 85 healthy control subjects. It was disclosed that the patients' mothers were also affected by diabetes mellitus in five of the six cases. In these six affected patients, the 3243 mutation shows variable phenotypes, such as the degree of multiple organ involvement, intrafamilial and interfamilial differences in disease characteristics, and the degree of the involvement of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) phenotype. Endocrinological examinations revealed that those diabetic patients with the 3243 mutation show not only beta-cell dysfunction, but also a defect in alpha-cell function, which is considered characteristic of diabetes with the 3243 mutation. When compared with 50 selected diabetic control subjects without the 3243 mutation, whose mothers, but not fathers, were found to have diabetes, it was established statistically that those with the 3243 mutation possess the following clinical characteristics; 1) the age of diabetes onset is lower, 2) they have lean body constitutions, and 3) they are more likely to be treated with insulin than control subjects. We suggest that diabetes with the 3243 mutation possesses phenotypes distinct from those in common forms of diabetes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713314     DOI: 10.1007/bf00400094

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  43 in total

1.  Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases.

Authors:  T P KEARNS; G P SAYRE
Journal:  AMA Arch Ophthalmol       Date:  1958-08

2.  Respiratory chain activity in tissues from patients (MELAS) with a point mutation of the mitochondrial genome [tRNA(Leu(UUR))].

Authors:  B Obermaier-Kusser; I Paetzke-Brunner; C Enter; J Müller-Höcker; S Zierz; W Ruitenbeek; K D Gerbitz
Journal:  FEBS Lett       Date:  1991-07-29       Impact factor: 4.124

3.  Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome.

Authors:  C T Moraes; S DiMauro; M Zeviani; A Lombes; S Shanske; A F Miranda; H Nakase; E Bonilla; L C Werneck; S Servidei
Journal:  N Engl J Med       Date:  1989-05-18       Impact factor: 91.245

4.  Adult-onset diabetes mellitus and neurosensory hearing loss in maternal relatives of MELAS patients in a family with the tRNA(Leu(UUR)) mutation.

Authors:  A M Remes; K Majamaa; R Herva; I E Hassinen
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

5.  The effects of metformin compared to the effects of phenformin on the lactate production and the metabolism of isolated parenchymal rat liver cell.

Authors:  O Jalling; C Olsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1984-05

6.  Mitochondrial genetics: a paradigm for aging and degenerative diseases?

Authors:  D C Wallace
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

7.  Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation.

Authors:  J B Buse; K Yasuda; T P Lay; T S Seo; A L Olson; J E Pessin; J H Karam; S Seino; G I Bell
Journal:  Diabetes       Date:  1992-11       Impact factor: 9.461

8.  Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease.

Authors:  E Kawasaki; H Takino; M Yano; S Uotani; K Matsumoto; Y Takao; Y Yamaguchi; S Akazawa; S Nagataki
Journal:  Diabetes       Date:  1994-01       Impact factor: 9.461

9.  Maternal effect and familial aggregation in NIDDM. The CODIAB Study. CODIAB-INSERM-ZENECA Study Group.

Authors:  F Thomas; B Balkau; F Vauzelle-Kervroedan; L Papoz
Journal:  Diabetes       Date:  1994-01       Impact factor: 9.461

10.  Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities ): disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature.

Authors:  N Fukuhara; S Tokiguchi; K Shirakawa; T Tsubaki
Journal:  J Neurol Sci       Date:  1980-07       Impact factor: 3.181

View more
  12 in total

1.  Prevalence of the mitochondrial DNA A1555G mutation in sensorineural deafness patients in island Southeast Asia.

Authors:  Safarina G Malik; Nova Pieter; Herawati Sudoyo; Abdul Kadir; Sangkot Marzuki
Journal:  J Hum Genet       Date:  2003-09-03       Impact factor: 3.172

2.  Could coenzyme Q10 and L-carnitine be a treatment for diabetes secondary to 3243 mutation of mtDNA?

Authors:  P Silvestre-Aillaud; D BenDahan; V Paquis-Fluckinger; J Pouget; J F Pelissier; C Desnuelle; P J Cozzone; B Vialettes
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

3.  Are MELAS and diabetes mellitus caused solely by the same mutation at np 3243 of the mitochondrial gene?

Authors:  M Odawara; K Yamashita
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

4.  Metabolic interventions against complex I deficiency in MELAS syndrome.

Authors:  K Majamaa; H Rusanen; A Remes; I E Hassinen
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

Review 5.  Maternally inherited diabetes and deafness: a new diabetes subtype.

Authors:  J A Maassen; T Kadowaki
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

Review 6.  Mitochondrial disease and endocrine dysfunction.

Authors:  Jasmine Chow; Joyeeta Rahman; John C Achermann; Mehul T Dattani; Shamima Rahman
Journal:  Nat Rev Endocrinol       Date:  2016-10-07       Impact factor: 43.330

7.  Nephropathy and growth hormone deficiency in a patient with mitochondrial tRNA(Leu(UUR)) mutation.

Authors:  T Yorifuji; M Kawai; T Momoi; H Sasaki; K Furusho; J Muroi; K Shimizu; Y Takahashi; M Matsumura; M Nambu; T Okuno
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

Review 8.  Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes.

Authors:  Roseanne O Yeung; Fady Hannah-Shmouni; Karen Niederhoffer; Mark A Walker
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

9.  Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry.

Authors:  Christina Reinauer; Thomas Meissner; Michael Roden; Angelika Thon; Paul-Martin Holterhus; Holger Haberland; Elisabeth Binder; Wolfgang Marg; Esther Bollow; Reinhard Holl
Journal:  Eur J Pediatr       Date:  2015-12-15       Impact factor: 3.183

10.  Characterisation of the macular dystrophy in patients with the A3243G mitochondrial DNA point mutation with fundus autofluorescence.

Authors:  P P Rath; S Jenkins; M Michaelides; A Smith; M G Sweeney; M B Davis; F W Fitzke; A C Bird
Journal:  Br J Ophthalmol       Date:  2008-05       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.